7月23日，奎斯特诊疗盘中上涨8.71%，报227.0美元/股，成交额4147.25万美元。消息面上，公司发布第二季度财报，业绩大幅超出市场预期并同步上调全年业绩指引。
具体数据显示，Q2调整后每股收益3.12美元，同比增长19.08%，超出市场一致预期2.83美元约10.25%；营收30.4亿美元，同比增长10.1%，高于预期的29.7亿美元。公司将全年调整后EPS指引上调至11.05-11.25美元区间，远超市场预期的10.75美元；全年营收指引上调至119.5-120.5亿美元，同样高于预期的118.5亿美元。这已是公司连续两个季度超预期并上修全年指引，反映出诊断服务需求持续旺盛及运营效率优化成效显著。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.